Investing Profile

Bali Muralidhar

InvestorVC

Managing Partner, Chief Investment Officer at Abingworth

abingworth.com/team/bali-mura...London

Your Intro Paths to Bali Muralidhar

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Networks Bali is a member of

IT CRUX Mobile Apps Solutions Network

397 CONNECTIONS

IT CRUX Mobile Apps Solutions Network

397 CONNECTIONS

IT CRUX Mobile Apps Solutions Network

397 CONNECTIONS

Bain & Company Network

342 CONNECTIONS

Bain Capital Network

275 CONNECTIONS

Find Bali Muralidhar on

cb

Current Investing Position

Abingworth Managing Partner

Investment Range

$15.0M - $30.0M

Sweet Spot

$22.5M

Investments On Record

14

Current Fund Size

$465M

Bali Muralidhar is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)Pharmaceuticals (Series A)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series A)London Health IT (Seed)Health & Hospital Services (Seed)

Bali Muralidhar's Investments On Record (12)

Company	StageDateRound Size	Total Raised
Cytospire Therapeutics	Series AMay 2026$83M	$83M
Co-investors: Owen Smith (4BIO Capital)
Wugen	Series CAug 2025$120M Series BJul 2021$170M	$290M
Co-investors: John McKearn (RiverVest Venture Partners), Niall O’Donnell (RiverVest)
Glycomine	Series CApr 2025$120M Series BJun 2021$35M	$150M
Co-investors: Jim Trenkle (Sanofi Ventures), Niall O’Donnell (RiverVest), Dominic Schmidt (Advent Life Sciences)
AdvanCell	Series CFeb 2025$110M	$110M
Co-investors: Jamil Beg (5am Ventures), Christopher Gagliardi (Sanofi Ventures)
Ascend Gene & Cell Therapies	Series AMar 2023$66M	$66M
Co-investors: Eric Shiozaki (DCVC (Data Collective)), Andrew Kozlov (4BIO Capital), Andrew Sinclair (Abingworth)
Anjarium Biosciences	Series ASep 2021$60M	$60M
CymaBay Therapeutics	Post Ipo DebtAug 2021$100M	$190M
Co-investors: Andrew Schwab (5am Ventures), Tony Evnin (Venrock)
Reneo Pharmaceuticals	Series BDec 2020$95M	$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest)

Bali Muralidhar's Experience

Clinical Fellow IT CRUX Mobile Apps SolutionsPresent

Researcher IT CRUX Mobile Apps SolutionsPresent

Bye-Fellow IT CRUX Mobile Apps SolutionsPresent

Consultant Bain & CompanyPresent

Associate Bain CapitalPresent

Partner MVM PartnersPresent

Partner AbingworthPresent

Managing Partner AbingworthPresent

Managing Partner, Chief Investment Officer AbingworthPresent

Non Executive Director British Business BankPresent

Global Head of Life Sciences AbingworthPresent

Bali Muralidhar's Education

University of Cambridge MA Medical Science

University of Oxford BMBCh Clinical medicine

University of Cambridge PhD Cancer biology

Investors who invest with Bali Muralidhar

Jacqueline Grant

Founders who looked at Bali Muralidhar's profile also looked at these Scouts & Angels

Christopher Priebe